Letitia James Goes to the Supreme Court
James attended a rally in support of defending access to mifepristone, which is used as part of a two-drug regimen for some abortions.
Source: newsweek.com
Mitigation Strategy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mitigation Strategy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mitigation Strategy Program Today - Breaking & Trending Today
How Pharmacy Curricula Should Adjust to Abortion Legislature
Curricula should require comprehensive training for providing contraceptive care, helping students perform duties confidently and competently.
Source: pharmacytimes.com
Boone Drug chooses to not dispense Mifepristone
HIGH COUNTRY — Boone Drug will not participate in the voluntary Mifepristone Risk Evaluation and Mitigation Strategy Program due to the organization’s belief that it has a responsibility to protect
Source: averyjournal.com
FDA Approval Mifepristone REMS Program Modification Expands Patient Access to Abortion Care | Sheppard Mullin Richter & Hampton LLP
The Food and Drug Administration (the “FDA”) has approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy (“REMS”) Program, increasing the accessibility of...
Source: jdsupra.com
FDA Approves Changes to REMS Program
The FDA approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy, REMS, Program. The FDA’s approval of commercial dispensing of mifepristone likely will not change the current practice of prescribing and dispensing mifepristone for abortion.
Source: natlawreview.com